Data as of Oct 20, 2026Based on 1,923 AI responses
Reviewed by Dimitry Apollonsky
AI summary
GRAIL is a healthcare company that provides the Galleri test, a blood-based multi-cancer early detection test that screens for more than 50 cancer types.
1%
across GRAIL’s markets · since Jul 5
Each engine’s share of its own answers across GRAIL’s markets · since Jul 5
This page is cited in 12% of the answers that name GRAIL.
Review this page on your site for accurate product details and clear explanations of who it helps.
All-time evidence through 2026-09-20.
Review the page on grail.com (opens in a new tab)grail.com 20%Other sites 80%
Question: Which diagnostic AI tools are strongest for early detection using imaging, blood tests, or wearable signals?
ChatGPT SearchSep 3, 2026
GRAIL's Galleri analyzes DNA methylation patterns in cell-free DNA and uses machine learning to identify a cancer signal and predict its likely tissue of origin.
Question: As a 45-year-old with a family history of cancer, which early-detection blood test should I consider?
Google AI ModeJul 10, 2026
These tests, such as GRAIL's Galleri , can detect signals from many types of cancer
Excerpts where GRAIL appeared in the AI's answer
The most widely known and clinically studied MCED test is the Galleri test developed by GRAIL.
GRAIL’s Galleri Test: This is currently one of the most widely known and commercially available MCED tests
Excerpts where GRAIL appeared in the AI's answer
Multi-Cancer Early Detection (MCED) tests (such as the GRAIL Galleri Test Go to product viewer dialog for this item. ) are emerging liquid biopsies
These tests, such as GRAIL's Galleri , can detect signals from many types of cancer
Excerpts where GRAIL appeared in the AI's answer
Grail Galleri Test: An emerging (not yet FDA-approved) blood test that can detect signals from 50+ cancers.
Excerpts where GRAIL appeared in the AI's answer
GRAIL (Galleri Test - Galleri/Multi-Cancer Early Detection): While not an isolated software tool, it uses sophisticated machine-learning classifiers
GRAIL's Galleri analyzes DNA methylation patterns in cell-free DNA and uses machine learning to identify a cancer signal and predict its likely tissue of origin.